| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/02/2011 | EP2290363A1 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds |
| 03/02/2011 | EP2290362A2 Synchronized analyte testing system |
| 03/02/2011 | EP2290361A1 Methods for selecting a colorectal carcinoma treatment |
| 03/02/2011 | EP2290358A2 Analyzing Instrument |
| 03/02/2011 | EP2290354A1 Process analyser |
| 03/02/2011 | EP2290353A1 Measuring apparatus for monitoring a transformer's oil |
| 03/02/2011 | EP2290351A2 Device and method for detecting molecular interactions |
| 03/02/2011 | EP2290349A1 Vibrating helical spring sensors and methods to operate the same |
| 03/02/2011 | EP2290109A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/02/2011 | EP2290108A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/02/2011 | EP2290107A1 Kunitz domain library |
| 03/02/2011 | EP2290105A1 Method for detecting cellular proliferative disorders |
| 03/02/2011 | EP2290101A2 Assay for nucleic acid detection employing nuclease protection fragments |
| 03/02/2011 | EP2290100A2 Kits for displacement Sandwich Immuno-PCR |
| 03/02/2011 | EP2290097A2 Method for determining biophysical properties |
| 03/02/2011 | EP2290095A1 Method and kit for the diagnosis of ulcerative colitis |
| 03/02/2011 | EP2290094A1 Methods for detecting Lp-PLA2 activity and inhibition of Lp-PLA2 activity |
| 03/02/2011 | EP2290093A2 Method for detecting PRP using a molecule containing at least one positive charge and/or at least one osidic bond and a ligand other than a proteinic ligand |
| 03/02/2011 | EP2290088A1 Methods for producing soluble multi-menbrane-spanning proteins |
| 03/02/2011 | EP2290087A2 Methods for producing soluble multi-membrane-spanning proteins |
| 03/02/2011 | EP2290086A2 Methods for producing soluble multi-membrane-spanning proteins |
| 03/02/2011 | EP2290083A1 Conserved neisserial antigens |
| 03/02/2011 | EP2290082A1 Streptococcus pyogenes antigens |
| 03/02/2011 | EP2290081A2 IL-17 homologous polypeptide and therapeutic uses thereof |
| 03/02/2011 | EP2290079A2 Neurotrophic factors |
| 03/02/2011 | EP2290062A1 Corynebacterium glutamicum gene encoding phosphoenolpyruvate carboxykinase |
| 03/02/2011 | EP2290056A2 Mutated Abl kinase domains |
| 03/02/2011 | EP2290055A2 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic and therapeutic applications |
| 03/02/2011 | EP2290053A1 Method for producing Influenza virus in protein-free cell culture medium |
| 03/02/2011 | EP2289942A2 Anti-HER2 antibody variants |
| 03/02/2011 | EP2289941A2 Administration of agents for the treatment of inflammation |
| 03/02/2011 | EP2289940A2 Treatment of metastatic disease |
| 03/02/2011 | EP2289939A2 PAN-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy |
| 03/02/2011 | EP2289935A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289934A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289933A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289932A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289931A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289930A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289929A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289928A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289927A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289926A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289925A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289924A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289923A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289922A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289921A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289920A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289919A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289918A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289917A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289916A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289915A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289914A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289913A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289912A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/02/2011 | EP2289910A2 Differential in tumour gene products and use of same |
| 03/02/2011 | EP2289909A1 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 03/02/2011 | EP2289907A2 Streptococcus agalactiae antigens I + II |
| 03/02/2011 | EP2289544A2 Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| 03/02/2011 | EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO) |
| 03/02/2011 | EP2289520A1 Use of acetylsalicylic acid for the prophylaxis and/or treatment of influenza virus infection. |
| 03/02/2011 | EP2289416A1 Body fluid testing device |
| 03/02/2011 | EP2289311A2 Corn event MIR604 |
| 03/02/2011 | EP2288923A2 Compositions and methods of treatment using modulators of motoneuron diseases |
| 03/02/2011 | EP2288922A1 Sensory receptors for chronic fatigue and pain and uses thereof |
| 03/02/2011 | EP2288921A1 Detection device |
| 03/02/2011 | EP2288920A1 Method for the determination of trichinella infections and diagnostic composition for such methods |
| 03/02/2011 | EP2288919A2 Improved imaging of immunomagnetically enriched rare cells |
| 03/02/2011 | EP2288918A1 Glp-1 receptor agonist bioassays |
| 03/02/2011 | EP2288917A1 Chip for determination of molecular structures and functions |
| 03/02/2011 | EP2288916A1 Immunochromatographic method and test system for determining at least one analyte in a test solution under examination |
| 03/02/2011 | EP2288915A1 Auto-calibration circuit or label and method of forming the same |
| 03/02/2011 | EP2288914A1 Detection of free chlorine in water |
| 03/02/2011 | EP2288908A2 Detection of trace chemicals and method therefor |
| 03/02/2011 | EP2288897A2 Method and system for concentrating particles from a solution |
| 03/02/2011 | EP2288886A1 Method and apparatus for measuring temperatures in connection with manufacturing of a glue board or a corresponding product |
| 03/02/2011 | EP2288741A1 Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy |
| 03/02/2011 | EP2288733A2 A high throughput protein interaction assay |
| 03/02/2011 | EP2288726A2 Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences |
| 03/02/2011 | EP2288723A1 Materials and methods relating to a g-protein coupled receptor |
| 03/02/2011 | EP2288721A1 Treatment prediction involving hmgcr protei |
| 03/02/2011 | EP2288720A1 Enzymatic analytical membrane, test device and method |
| 03/02/2011 | EP2288719A2 Methods for diagnosis of clostridium diffcile and methods and vectors for recombinant toxin expression |
| 03/02/2011 | EP2288693A1 Novel astrovirus |
| 03/02/2011 | EP2288621A2 Il-23 receptor antagonists and uses thereof |
| 03/02/2011 | EP2288374A2 Novel n-and c-terminal substituted antagonistic analogs of human gh-rh |
| 03/02/2011 | EP2095118B1 Method of predicting phospholipidosis inducing properties of a substance |
| 03/02/2011 | EP2008097B1 Biosensor having nano wire and manufacturing method thereof |
| 03/02/2011 | EP1984736B1 Cd86 and cd80 receptor competition assays |
| 03/02/2011 | EP1934258B1 Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| 03/02/2011 | EP1907859B1 Genes and polypeptides relating to prostate cancers |
| 03/02/2011 | EP1828777B1 Labeled transition metal complexes |
| 03/02/2011 | EP1814386B1 Methods of studying tolerance in mhc-ii transgenic animals |
| 03/02/2011 | EP1805518B1 Fiber optic for sensing analytes and method of making same |
| 03/02/2011 | EP1771475B1 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 03/02/2011 | EP1766420B1 Device and method for automatically analysing blood samples |
| 03/02/2011 | EP1740699B1 Connexin 40 tissue specific gene mutations |
| 03/02/2011 | EP1725871B1 Separation of unconjugated and conjugated saccharides by solid phase extraction |